Consolidated Statement of Cash Flows (Unaudited) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 29, 2012	Oct. 01, 2011
Operating Activities
Net income	$ 801.5	$ 1,041.0
Loss (income) from discontinued operations	15.4	(4.7)
Loss (gain) on disposal of discontinued operations	55.7	(305.4)
Income from continuing operations	872.6	730.9
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:
Depreciation and amortization	729.3	614.0
Change in deferred income taxes	(243.3)	(182.3)
Non-cash stock-based compensation	57.8	60.6
Non-cash charges for sale of inventories revalued at the date of acquisition	40.1	40.5
Tax benefits from stock-based compensation awards	(12.8)	(16.6)
Other non-cash expenses, net	29.1	36.6
Changes in assets and liabilities, excluding the effects of acquisitions and dispositions:
Accounts receivable	(16.2)	(76.0)
Inventories	(132.6)	(62.3)
Other assets	(81.2)	(66.2)
Accounts payable	71.2	29.0
Other liabilities	102.9	(54.7)
Contributions to retirement plans	(16.3)	(16.8)
Net cash provided by continuing operations	1,400.6	1,036.7
Net cash (used in) provided by discontinued operations	(21.2)	17.3
Net cash provided by operating activities	1,379.4	1,054.0
Investing Activities
Acquisitions, net of cash acquired	(1,072.4)	(5,691.1)
Purchase of property, plant and equipment	(210.7)	(180.2)
Proceeds from sale of property, plant and equipment	11.6	6.2
Proceeds from sale of businesses, net of cash divested		13.8
Other investing activities, net	1.7	(2.2)
Net cash used in continuing operations	(1,269.8)	(5,853.5)
Net cash provided by discontinued operations	3.4	784.1
Net cash used in investing activities	(1,266.4)	(5,069.4)
Financing Activities
Net proceeds from issuance of long-term debt	1,282.3	4,254.4
(Decrease) increase in commercial paper, net	(849.3)	999.3
Settlement of convertible debt		(452.0)
Redemption and repayment of long-term obligations	(2.0)	(0.9)
Purchases of company common stock	(800.0)	(987.5)
Dividends paid	(95.3)
Net proceeds from issuance of company common stock	131.3	153.7
Tax benefits from stock-based compensation awards	12.8	16.6
Increase in short-term notes payable	14.4	9.3
Other financing activities, net	(4.5)	4.1
Net cash (used in) provided by financing activities	(310.3)	3,997.0
Exchange Rate Effect on Cash	13.2	(8.4)
Decrease in Cash and Cash Equivalents	(184.1)	(26.8)
Cash and Cash Equivalents at Beginning of Period	1,016.3	917.1
Cash and Cash Equivalents at End of Period	$ 832.2	$ 890.3